|
Drugs used for Alzheimer's disease |
||
|
Drug class |
Adverse effects |
Key points |
|
Acetylcholinesterase inhibitors |
|
|
|
|
|
|
|
|
|
NMDA inhibitor |
|
|
|
Amyloid beta monoclonal antibodies |
|
|
|
*All strengths of Namzaric contain donepezil 10 mg; donepezil requires titration from a starting dose of 5 mg to avoid gastrointestinal adverse effects. ER = extended release; NMDA = N-methyl-D-aspartate. |
||